SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer

Author:

Borghaei H.ORCID,de Marinis F.,Dumoulin D.ORCID,Reynolds C.,Theelen W.S.M.E.ORCID,Percent I.,Gutierrez Calderon V.,Johnson M.L.,Madroszyk-Flandin A.ORCID,Garon E.B.ORCID,He K.,Planchard D.,Reck M.,Popat S.ORCID,Herbst R.S.,Leal T.A.ORCID,Shazer R.L.ORCID,Yan X.,Harrigan R.,Peters S.ORCID,Abdel-Karim Isam,Abdelsalam Mahmoud,Addeo Alfredo,Aguado Carlos,Alexander Patrick,Alt Jürgen,Azzi Georges,Balaraman Rama,Biesma Bonne,Blackhall Fiona,Bohnet Sabine,Boleti Ekaterini,Borghaei Hossein,Bradbury Penelope,Brighenti Matteo,Campbell Nicholas,Campbell Toby,Canon Jean-Luc,Cappuzzo Federico,Costa Enric Carcereny,Cavanna Luigi,Cetnar Jeremy,Chella Antonio,Chouaid Christos,Christoph Daniel,Castán Javier Cortés,Dakhil Shaker,de Castro Carpeño Francisco Javier,de Marinis Filippo,Delmonte Angelo,Demedts Ingel,Demey Wim,Dits Joyce,del Pilar Diz Taín Maria,Gómez Manuel Dómine,Dorius Timothy,Dumoulin Daphne,Duruisseaux Michaël,Eaton Keith,González Emilio Esteban,Evans Devon,Faehling Martin,Farrell Nicholas,Feinstein Trevor,Font Enriqueta Felip,Garcia Campelo Maria Rosario,Garon Edward,Garrido López María Pilar,Germonpré Paul,Gersten Todd,Cao Maria Gonzalez,Gopaluni Srivalli,Greillier Laurent,Grossi Francesco,Guisier Florian,Gurubhagavatula Sarada,Calderón Vanesa Gutiérrez,Hakimian David,Hall Richard,Hao Desirée,Harris Ronald,Hashemi Sayed,He Kai,Hendriks Lizza,Huang Chao,Ibrahim Emad,Jain Sharad,Johnson Melissa,Jones Benjamin,Jones Monte,Juan Vidal Óscar José,Juergens Rosalyn,Kaderbhai Courèche,Kastelijn Elisabeth A (Lisanne),Keresztes Roger,Kio Ebenezer,Kokowski Konrad,Konduri Kartik,Kulkarni Swati,Kuon Jonas,Kurkjian Carla,Labbé Catherine,Lerner Rachel,Lim Farah,Madroszyk-Flandin Anne,Marathe Omkar,Martincic Danko,McClay Edward,McIntyre Kristi,Mekhail Tarek,Misino Andrea,Molinier Olivier,Morabito Alessandro,Morócz Éva,Müller Veronika,Nagy Tünde,Nguyen Anthony V.,Nidhiry Emmanuel,Okazaki Ian,Ortega-Granados Ana Laura,Ostoros Gyula,Oubre David,Owen Scott,Pachipala Krishna,Park David,Patel Pareshkumar,Percent Ivor,Pérol Maurice,Peters Solange,Piet Berber,Planchard David,Polychronis Andreas,Aix Santiago Ponce,Pons-Tostivint Elvire,Popat Sanjaykumar,Pulla Mariano Provencio,Quantin Xavier,Quéré Gilles,Rafique Noman,Ramaekers Ryan,Reck Martin,Reiman Anthony,Reinmuth Niels,Reynolds Craig,Rodríguez-Abreu Delvys,Romano Gianpiero,Roque Tammy,Salzberg Matthew,Sanborn Rachel,Sandiego Sergio,Schaefer Eric,Schreeder Marshall,Seetharamu Nagashree,Seneviratne Lasika,Shah Purvi,Shunyakov Leonid,Slater Dennis,Parra Hector Soto,Stigt Johannes,Stilwill Joseph,Su Jingdong,Surmont Veerle,Swink Alicia,Szalai Zsuzsanna,Talbot Toby,Garcia Alvaro Taus,Theelen Willemijn,Thompson Jonathan,Tiseo Marcello,Uprety Dipesh,Uyeki James,van der Leest Kornelius Cor,Van Ho Anthony,van Putten John,Estévez Sergio Vázquez,Veatch Andrea,Vergnenègre Alain,Ward Patrick,Weise Amy,Weiss Matthias,Whitehurst Matthew,Zai Silvia,Zalcman Gérard,Zuniga Richard

Funder

Bristol-Myers Squibb

Mirati Therapeutics

Publisher

Elsevier BV

Subject

Oncology,Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3